PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome-Reference-Cited by-同舟云学术

PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome

Published:2008-04 Issue:4 Volume:179 Page:1587-1592
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Deras Ina L.¹,Aubin Sheila M.J.¹,Blase Amy¹,Day John R.¹,Koo Seongjoon¹,Partin Alan W.²,Ellis William J.³,Marks Leonard S.⁴,Fradet Yves⁵,Rittenhouse Harry¹,Groskopf Jack¹

Affiliation:

1. Gen-Probe, Inc., San Diego, California

2. The Johns Hopkins Medical Institutions, Baltimore, Maryland

3. University of Washington, Seattle, Washington

4. Urological Sciences Research Foundation, Los Angeles, California

5. Diagnocure Inc. and Université Laval, Quebec City, Quebec, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Screening for prostate cancer with prostate-specific antigen: beware the biases;Bunting;Clin Chim Acta,2002

2. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial;Thompson;J Natl Cancer Inst,2006

3. An evaluation of prostate specific antigen in prostatic cancer;Guinan;J Urol,1987

4. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate;Stamey;N Engl J Med,1987

5. The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration;Tchetgen;Urol Clin North Am,1997

Cited by 380 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LINC00654–SOX5 mRNA-miRNA-133a Compose New RNA Panel for Colorectal Cancer (CRC): A Potential Diagnostic Panel for CRC;Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry;2024-06

2. Urinary PSA-ZINC biomarker outperforms standard of care in early detection of prostate cancer;Minerva Urology and Nephrology;2024-06

3. Established and emerging liquid biomarkers for prostate cancer detection: A review;Urologic Oncology: Seminars and Original Investigations;2024-06

4. Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives;Cancers;2023-09-27

5. The performance and limitations of PCA3, TMPRSS2:ERG, HOXC6 and DLX1 urinary markers combined in the improvement of prostate cancer diagnostics;Clinical Biochemistry;2023-06